COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.
Stay current on PCCA news and events, market trends, and all things compounding!
Scientists detected evidence of DNA methylation abnormalities in patients with autism spectrum disorder (ASD). Learn how compounders may potentially help ASD patients with methylcobalamin preparations.
Learn why methylene blue, synthesized in 1876 as a dye for the textile industry, has rekindled interest for therapeutic use in diseases.
Read why Kayla Valigura, PharmD candidate and 2022 PCCA Institute Scholarship award winner, wants your help in acting on something near and dear to her heart.
PCCA's Matt Martin and Melissa Merrell Rhoads provide guidance and examples to help you determine API calculations in your compounding pharmacy.
We’re reviewing the distinctions between SuspendIt and SuspendIt Anhydrous, as well as how revisions to USP Chapter 795 will guide beyond use dates (BUDs) for aqueous and nonaqueous oral dosage forms.
PCCA Clinical Compounding Pharmacist Sebastian Denison, RPh, FAARM (candidate), updates a 2016 Apothagram article and shares heart healthy tips that reignite the libido.
PCCA Director of Formulations Melissa Merrell Rhoads, PharmD, offers insights on working with SuspendIt Anhydrous in oral suspension formulations
A modular compounding cleanroom is a great way to meet evolving regulatory requirements and standards. Learn the basics of a modular cleanroom in the first in a series of articles on Modular Compounding Cleanrooms.
Our PCCA Clinical Compounding Pharmacist Don Bottoni continues to discuss the gut-brain connection and ways to restore gut health.
Our PCCA Clinical Compounding Pharmacist Don Bottoni reviews the gut-brain connection and how it plays a major role in health and disease.